Table 1 Comparing characteristics of patients with and without significant fibrosis
Variables | Patients without significant fibrosis (F0-1), n = 329 | Patients with significant fibrosis (F2-4), n = 126 | χ2 value | P |
|---|---|---|---|---|
Age | 29(16-60) | 40(17-75) | 52.21 | < 0.0001 |
Gender(M/F) | 215/114 | 74/52 | 1.723 | 0.189 |
WBC(109/L) | 5.3(2.3-12.2) | 4.5(1.3-18.1) | 14.51 | < 0.0001 |
RBC(1012/L) | 4.8(3.5-4.0) | 4.5(2.6-5.7) | 9.47 | 0.002 |
Hb(g/L) | 145(87-173) | 141(85-167) | 1.79 | 0.174 |
Platelet(109/L) | 184(46-350) | 136(13-246) | 80.24 | < 0.0001 |
ALT(U/L) | 72.0(6-471) | 174.1(11-536) | 11.37 | < 0.001 |
AST(U/L) | 15.2(11-341) | 63.4(11-413) | 28.43 | < 0.0001 |
GGT(u/L) | 24.9(6-473) | 66.5(8-327) | 62.14 | < 0.0001 |
ALP(u/L) | 106(7-219) | 117(19-307) | 2.78 | 0.099 |
ChE(u/L) | 8054(70-20427) | 6617(50-12648) | 41.28 | < 0.0001 |
TP(g/L) | 72.3(49-88.4) | 72.1(40-88.3) | 0.442 | 0.501 |
Alb(g/L) | 45.4(11.6-47.0) | 43.2(10.9-52.6) | 18.14 | < 0.0001 |
TBIL(μmol/L) | 13.4(3-138) | 15.3(5.5-216) | 11.03 | < 0.0001 |
Length of liver biopsy(mm) | 14(10-21) | 12(11-19) | 1.290 | 0.256 |
Number of liver biopsy | 2.0(1.0-4.0) | 2.5(1.0-5.0) | 1.621 | 0.197 |